The simple diamine diaminoethane (ethylenediamine, EDA) has been shown to activate GABA receptors in the central and peripheral nervous systems, partly by a direct action and partly by releasing endogenous GABA. These effects have been shown to be produced by the complexation of EDA with bicarbonate to form a carbamate. The present work has compared EDA, GABA and β-alanine responses in rat CA1 neurons using extracellular and intracellular recordings, as well as neocortical evoked potentials in vivo. Superfusion of GABA onto hippocampal slices produced depolarisation and a decrease of field epsps, both effects fading rapidly, but showing sensitivity to blockade by bicuculline. EDA produced an initial hyperpolarisation and increase of extracellular field epsp size with no fade and only partial sensitivity to bicuculline, with subsequent depolarisation, while β-alanine produces a much larger underlying hyperpolarisation and increase in fepsps, followed by depolarisation and inhibition of fepsps. The responses to β-alanine, but not GABA or EDA, were blocked by strychnine. In vivo experiments, recording somatosensory evoked potentials, confirmed that EDA produced an initial increase followed by depression, and that this effect was not fully blocked by bicuculline.
INTRODUCTION
Ethylenediamine (1,2-diaminoethane, EDA) is used as a complexing and solubilising agent in preparations such aminophylline, which is a complex of EDA and theophylline. When aminophylline was applied by microiontophoresis to spontaneously firing neurones in vivo (Stone and Perkins, 1979) it produced a depression of neuronal firing, leading to the realisation that the inhibition was entirely attributable to the EDA, not the theophylline component of the complex Stone, 1980,1982a; Perkins et al., 1981) . This conclusion was confirmed by others studying neuronal activity in the hippocampus (Blaxter and Cottrell 1985) , cerebellum and invertebrate CNS (Bokisch et al., 1984) .
Both EDA and GABA showed the same reversal potential, the depressant activity was blocked by bicuculline Perkins and Stone, 1982a ) and potentiated by benzodiazepines (Bokisch et al., 1984) . Neurochemical analyses showed that EDA could be transported into GABA-containing synaptic terminals, provoking the selective release of GABA but not dopamine (Lloyd et al., 1982a,b; Ong, 1982, 1987; Sarthy, 1983) . Overall, EDA was a GABA-mimetic, acting partly indirectly by GABA release (either by uptake and displacement of synaptic GABA or by promoting the exchange of GABA for EDA) and partly by direct activation of GABA A receptors (Morgan and Stone, 1982; Davies et al., 1982) . Later work indicated that EDA can activate GABA receptors in smooth muscle Barbier et al, 1989; Maggi et al., 1989; Chaudhuri and Ganguly, 1994, Begg et al., 2002) , partly via endogenous GABA release (Kerr and Ong, 1984; Erdo et al., 1986; Mckay and Krantis, 1991) .
In order to explain this neuronal inhibition by a simple amine lacking any oxygencontaining functional group, it was proposed that the positively charged amine groups of EDA might interact with bicarbonate ions in solution (Stone and Perkins, 1984) to generate an aliphatic structure resembling GABA. The existence of the postulated complex was subsequently confirmed and identified as EDA monocarbamate (Curtis and Malik, 1984; Kerr and Ong, 1987) , which reproduced the activity of EDA.
Analogues with longer or branched structures are much less effective as GABAmimetics .
The similarity between EDA and GABA pharmacology extended to the ability of nipecotic acid to inhibit EDA uptake in brain slices (Lloyd et al., 1982b) and the ability of depolarising stimuli to release EDA in a calcium-dependent fashion.
Overall, these results indicated that EDA might make a valuable tool to explore aspects of GABA synaptic pharmacology, promoting the effects of endogenous GABA released from synaptic terminals. However, there remain several unanswered questions. For example, GABA acts on CA1 apical dendrites with a hyperpolarisation that is not blocked by bicuculline (Alger and Nicoll, 1982) although it is still mediated via GABA A and not GABA B receptors. Therefore, the present study was designed to re-examine the pharmacology of EDA under the controllable conditions of hippocampal slices. In addition, it was of interest to examine the effects of EDA in vivo, where the intercellular milieu is more complex and adaptive than under in vitro conditions.
MATERIALS AND METHODS

General
All procedures performed in this work were in accordance with the regulations and recommendations of the Animals (Scientific Procedures) Act, 1986 of the United Kingdom Home Office. Hippocampal slices were prepared as described previously (see Stone, 2007; Ferguson and Stone, 2008) . Briefly, male Wistar rats weighing 100-150g were killed by administering an overdose of urethane (10ml/kg body weight i.p., as a 25% solution in water) followed by cervical dislocation. The brain was rapidly removed into ice-cold artificial cerebrospinal fluid (aCSF) of composition: (in mM) NaCl 115; KH 2 PO 4 2.2; KCl 2; MgSO 4 1.2; NaHCO 3 25; CaCl 2 2.5; Dglucose 10, gassed with 5%CO 2 in oxygen. The hippocampi were chopped into 450µm transverse slices using a McIlwain tissue chopper. The slices were preincubated at room temperature for at least 1 hour in a water-saturated atmosphere of 5%CO 2 in O 2 before individual slices were transferred to a 1 ml capacity superfusion chamber for recording.
For extracellular recording, submerged slices were superfused with aCSF at 28-30°C and a flow rate of 3-4 ml/min. The Schaffer collaterals and commissural afferents to the CA1 region were stimulated using a concentric bipolar electrode (Harvard Apparatus, Edenbridge, UK) positioned in the stratum radiatum, (0.1 Hz stimulation using a pulse duration of 50-300µs. The stimulating electrode tip was located immediately internal to the stratum pyramidale at the border between the CA1 and CA2 regions. For antidromically-evoked potentials, the stimulating electrode was placed in contact with the alvear white matter containing the axons of the pyramidal neurons. Recording electrodes were constructed from fibre-containing borosilicate glass capillary tubing (Harvard Apparatus, Edenbridge, Kent, UK), with the tips broken back under microscopic control to 2-4µM, DC resistance approximately 5MΩ. These electrodes were filled with a solution of 1M NaCl. The recording electrode tip was placed either in the stratum pyramidale (for population spike recordings) or internal to the CA1 pyramidal cell layer at the point of maximum epsp amplitude. The potentials were amplified and captured on a micro1401 interface (CED, Cambridge Electronic Design, Cambridge, UK) for storage on computer and subsequent analysis using Signal software (CED, Cambridge, UK). The amplitude of population spikes was taken as the potential difference between the negative and positive peaks of the potential. The negative slope of the epsp was taken as the gradient of the line of best fit of all sampled points between approx. 25% and 75% after the start of the negative slope. The epsp amplitude was taken as the potential difference between the negative peak of the epsp and the pre-stimulus baseline.
Intracellular recordings were made as described previously (Stone, 2007) , using sharp electrodes pulled from fibre-containing glass capillary tubing (Clark Electromedical, Reading, UK, and Harvard Apparatus, Edenbridge, UK) using a vertical Narashige puller. The electrodes were filled with 1M potassium acetate, and had tip resistances of 90-120 MΩ. Potentials were amplified via an Axoclamp-2 system or Neurolog DC amplifier in bridge balance mode, with a filter bandwidth between DC and 500Hz to reduce higher frequency components of epsp recordings.
Following penetration, cells were allowed to reach a maximum resting potential and then left for 30 min before the addition of compounds into the superfusion line. Cells were only used if they exhibited stable resting potentials of at least -60mV. Neuronal excitability was tested by applying intracellular depolarising current pulses between 0.05 and 1.0nA amplitude. Input resistance was monitored using 0.05 to 1.0nA hyperpolarizing pulses. Responses were digitised at 20kHz via a CED (Cambridge Electronic Design, Cambridge, UK) micro1401 interface and stored on computer for later analysis using the Signal programme (CED). Only one cell was studied in each slice, to preclude the possibility that drug superfusion might alter the responsiveness of subsequent neurons in the same slice.
In vivo electrophysiology
The in vivo work was approved by the local Ethics Committee for the use of animals. Male Sprague Dawley rats weighing 200-320g were housed and maintained at the animal care facility of the university's veterinary hospital according to the standards of the local ethics committee. The rats had free access to food and water with a 12 hour light/dark cycle. The experimental procedures we used for recording somatosensory evoked potentials (SEPs) have been described in previous reports (Addae et al., 2000 (Addae et al., , 2007 . Briefly, following anesthesia with urethane (1.5-1.7 g/kg) the rats were mounted in a stereotaxic frame and the body temperature maintained and bicuculline methobromide were dissolved in the aCSF, although when EDA was being applied at high concentrations it was dissolved in aCSF with reduced concentrations of NaCl to maintain isotonicity of the solution.
Data are expressed as mean ± S.E.M.. Statistical comparisons of two data sets were made with an unpaired Student's t-test. Comparisons of multiple data sets were made using ANOVA.
Statistics
Data are presented throughout as mean ± standard error. Baseline values were obtained from a stable 10min period of evoked potential size prior to the addition of any drugs, with the first of those potentials being defined as 100%. This allowed the 10min pre-drug period to provide an indication of baseline variance. For statistical comparisons between two groups, unpaired, two-tailed t-tests were used, but where two or more data sets were compared with a common control, an analysis of variance (ANOVA) was performed, followed by Dunnett's test for comparisons with a common control, or the Bonferroni test for selected pairs of columns as appropriate.
All analyses were conducted using Instat software.
Sources
Glutamate, 4-aminobutyric acid (GABA), glycine, β-alanine, adipic acid, α-aminoadipic acid, ethylenediamine dihydrochloride (EDA), strychnine and nipecotic acid, were obtained from Sigma-Aldrich Chemical Company, Poole, UK.
(-)bicuculline methobromide (BIC), 3-((R)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP), (3-aminopropyl)(diethoxymethyl)phosphinic acid (CGP35348) and gabazine were obtained from Tocris Chemicals, Bristol, UK.
RESULTS
Responses to EDA and GABA
The main response to EDA was a reduction in the size of fepsps (Fig. 1A,B) . The time course of responses is illustrated by the family of curves obtained in response to maintained (10min) applications of EDA such that responses reached a plateau (Fig.1A) . The corresponding log concentration-response curves are constructed in Fig.1C . When perfusion with EDA was maintained until this plateau of depression, a significant effect could be seen at a concentration as low as 50µM (Fig. 1B,C) . None of these responses to EDA were associated with any changes in the size of the axonal volley (Fig.1B) . In an initial series of 16 slices tested with EDA at 1mM or above, 4 slices showed a depression of fepsps which was preceded by a small increase in size which reached 120.9 ± 2.2% of the initial baseline (n = 4, significantly different from baseline, P = 0.006), and was not clearly related to concentration.
At concentrations below approximately 1mM, the effects of EDA were normally fully reversible, with potential size returning to levels not significantly different from the initial baseline values (Fig. 1A) . At concentrations of 1 mM or above, a proportion of slices showed a long-lasting depression of fepsp size. Overall, of the initial group of 16 slices perfused with EDA alone at 1mM or above, 12 showed a fully reversible depressant effect of EDA on fepsps, while 4 showed persistent depression after recovering only partially towards baseline levels. This long-lasting depression was even more evident when slices were perfused for a shorter period of 5min (Fig. 1D ).
For comparison, GABA was superfused over slices at a range of concentrations similar to those used for EDA (Fig. 1C) . The responses obtained were of a broadly similar magnitude and time course to those seen with EDA, although there were no instances of initial increases in fepsp size, and all responses returned to the baseline levels, with no maintained depression. Indeed, when applied at concentrations of 500µM or above for 10min, the fepsp size reached a peak of depression after about 1min, before this effect began to fade, starting to recover towards baseline values during the continued presence of GABA. In these cases, for the purpose of constructing the concentration-response curve in Fig. 1C , the amplitude of the response was taken as the maximum extent of the depression.
GABA receptor blockade
In order to examine the pharmacology of these responses, EDA was applied at a concentration of 1mM for periods of 2 min, once every 10-15 min. This protocol allowed the establishment of two consistent control responses, followed by the application of a potential modulator and then recovery of the original EDA response.
The results were discarded from any slices in which the EDA response did not recover to within 10% of its initial value.
The application of bicuculline methobromide to slices tends to result in the development of multiple population spikes in the recordings of fepsp, together with the occurrence of spontaneous epileptiform bursting. These experiments were therefore conducted in slices in which a cut was made between the CA3 and CA1
regions, approximately at the border between CA2 and CA3. While this did not completely prevent signs of hyperexcitability, the changes seen did not interfere with the overall behaviour of the slices, or affect their eventual recovery. Since bicuculline is known to affect some receptors and channels in addition to those for GABA, experiments were also performed using gabazine, a highly selective antagonist at GABA A receptors. In these cases, a similar, partial antagonism of EDA was seen when gabazine (20µM) was used, a concentration known to block GABA A receptors (Lindquist et al., 2005) (Fig. 2C) . A higher concentration of 100µM did not produce a significantly greater reduction of the EDA response ( Fig. 2C ).
In contrast to these results, bicuculline at 20µM produced a complete blockade of the responses to GABA (1mM; data not shown). On the other hand, neither strychnine (10 or 100µM) ( Fig. 2C ) nor the GABA B receptor antagonist CGP35348 (100µM; data not shown) were able to produce any significant reduction in the size of responses to EDA.
Similarly, perfusion with neither bicuculline nor strychnine produced any change in the size of the initial increase of fepsp size. On those slices showing this aspect of the response, the fepsp size was increased by 16.43 ± 1.20% with EDA alone (n = 3); 16.87 ± 2.89% with EDA and bicuculline (n = 3); and 16.77 ± 2.5% with EDA and strychnine (n = 3). These increases were not significantly different (ANOVA (F(2,8) = 0.0096; P = 0.99).
Nipecotic acid
The GABA transport (GAT-1) inhibitor nipecotic acid (100µM) was applied for 10min before and during a series of applications of EDA. The concentration of 100µM was selected as one which had no effect alone on the fepsp size. With this protocol, nipecotic acid produced a gradual enhancement of the size (Fig. 3A ,B,C) and particularly the duration of responses to EDA, with no change in the size of the axonal volley (Fig. 3B) . The potentiation of EDA responses recovered to a level not significantly different from the original values (Fig. 3A,C,D) 
Chelation
EDA is well-established as a chelator of metal ions, for which property it is widely used in the chemical synthesis of organo-metallic complexes, it was considered that the depression of evoked potentials, particularly that component of the depression that was not prevented by bicuculline or gabazine, might reflect the chelation of Ca++ ions. Doubling the calcium content of the aCSF increased the size of the baseline fepsp by approximately 20%, but did not reduce the percentage fepsp depression produced by 500µM EDA (41.6 ± 3.7%, n = 4 in normal aCSF, 38.8 ± 1.7%, n = 4 in elevated calcium, P = 0.53) . Similarly the possibility was also considered that the initial increase in fepsp slope seen in some slices (see above) might result from the chelation of Mg++, possibly resulting in an initial overdepolarisation of slices caused by increased sensitivity of NMDA receptors. When a slice was encountered in which EDA produced a clear and reproducible initial increase of fepsp size, the selective NMDA receptor antagonist CPP (10µM) was superfused. However, CPP did not prevent either the early hyperexcitability (control increase 18.23 ± 3.6%, with CPP 22.8 ± 3.8%, n = 3, P = 0.44) or the predominant depression of fepsp slope (control depression 50.9 ± 5.6%, with CPP 44.9 ± 6.3, n = 4, P = 0.51).
Antidromic potentials
The foregoing results suggest thatsome of the depression of fepsps produced by EDA could be attributed to activation of GABA A receptors, but the origin of the occasional increase of excitability, and of that fraction of neuronal inhibition that was not blocked by bicuculline, remained unclear. It was therefore decided to test EDA on non-synaptic potentials evoked by the antidromic activation of CA1 pyramidal cells.
Even with this paradigm, EDA at 300µM continued to depress the amplitude of the antidromic population spikes (Fig. 4A,B ). When these slices were superfused with kynurenic acid, a non-selective antagonist at glutamate receptors Stone 2001) , using a concentration of 2mM, there was no significant change in the size of the EDA-induced depression (Fig. 4A,B ).
β-alanine
In addition to forming a GABA-like agonist complex, the structure of EDA might lend itself to the formation of a complex or carbamate compound similar in electronic structure to β-alanine, which has inhibitory activity on central neurons. Applications of β-alanine depressed orthodromic potentials with a potency comparable to that of EDA ( Fig. 5A) , producing a reduction in the fepsp of 83.05 ± 3.48% (n = 5) at a concentration of 2mM and 44.72 ± 3.94% (n = 4) at 500µM. Superfusion with bicuculline at 100µM did not change the depression of fepsps whereas strychnine (20µM) produced a selective block of the depressant response which developed during a strychnine application lasting 30min (Fig. 5A,B) .
The depression of fepsps by β-alanine was preceded in most cases (7 of 8 slices tested using 500µM) by a significant increase in the slope of the potential (Fig. 5A ).
the initial increase sometimes seen with EDA. The initial increase of fepsp size was not reduced by superfusion with bicuculline or strychnine (Fig. 5A,C) .
Intracellular recordings
Since the foregoing results presented a complicated picture of mixed excitatory and inhibitory components in the response to EDA, experiments were performed to address further the mechanism of action of EDA by intracellular recordings using classical sharp electrodes. A total of 22 neurones in the CA1 pyramidal layer were recorded (in separate slices), with resting membrane potentials ranging from -66 to81mV. The application of EDA to the slices for 2min produced, in most cases (16 of 22), and at both the 300µM or 1mM concentrations examined, a rapid depolarisation of the neurones (Fig. 6A ).
The depolarisations produced by EDA at 1mM reached 27.93 ± 2.0 mV (n = 16).
This depolarisation was associated with a marked decrease of membrane input resistance from baseline values of 57.9 ± 3.8 MΩ to 32.3 ± 2.5 MΩ (P = 0.0002; n = 6) (Fig. 6A,B) , the decreased resistance still being apparent when the membrane potential was clamped at the original resting potential (Fig. 6C) . The application of concentrations greater than 1mM usually resulted in overdepolarisation of the neurones.
In several cases (6 of 22 cells), the depolarisation was preceded and followed by a marked hyperpolarisation (Fig. 6B ) which reached 9.75mV ± 2.15 in those 6
neurons, all of which were treated with EDA at 1mM.
The mechanism of the EDA-induced depolarisation was probed by perfusing with kynurenic acid (2mM) for 10 min before, during and for 10min following EDA (500µM). Kynurenic acid produced only small and non-significant changes in the size of the overall EDA depolarisations, which were reduced from 22.2 ± 3.6 mV to 21.1 ± 3.9 mV (P = 0.83, n = 4).
Superfusion with bicuculline (20µM) reduced the amplitude of EDA depolarisations elicited at 1mM (Fig. 7A,B) or 300µM concentrations, an effect which reached a maximum plateau after about 30 min of superfusion, consistent with the effects seen using synaptically-evoked potentials (above). Strychnine 20µM did not change the magnitude of the EDA depolarisations (controls 26.6mV ± 3.6mV, with strychnine 24.3 ± 2.9mV, n = 4, P = 0.64).
Applications of GABA for 2 min (1mM) generated complex responses which in most cases (5 of 7 cells) involved an early depolarisation which attained a peak within about 30secs and then declined substantially during the presence of GABA.
These responses closely resembled in profile the changes of extracellularly recorded fepsps described above. The responses were fully blocked by superfusion with bicuculline (20µM), but not strychnine (20µM), and were unaffected by the GABA B receptor antagonist CGP35348 (100µM)(data not shown).
When applied during intracellular recording, β-alanine (1mM) produced a depolarisation of 22.3mV ± 3.1 (n = 4), preceded in 3 cases by an initial and subsequent hyperpolarisation (6.4mV ± 0.69, n = 3) very similar to those seen with EDA (above, Fig. 6B ). Strychnine produced a gradual blockade of the depolarising phase of these responses (to 8.9mV ± 2.7, n = 4, P = 0.002 using paired t test), with no effect on the hyperpolarisations (6.0mV ± 0.67, n = 3, P = 0.72). Bicuculline (100µM) had no significant effect on either component of the β-alanine responses.
Adipic acid
Given the chemical structure of EDA, and previous evidence for its ability to form acidic complexes with bicarbonate ions, the possibility was considered that a similar di-carboxy adduct might be responsible for the bicuculline-resistant neuronal depolarisation. Such an adduct should most closely resemble adipic acid in structure,
and this compound was therefore tested on slices.
Adipic acid itself produced little effect at 1mM, with small and inconsistent effects at 2mM. At a concentration of 10mM it produced changes of the fepsps which were either increased (22.6 ± 3.0%, n = 4, significantly different from baseline, P = 0.005), or decreased (21.8 ± 3.3%, n = 5, significantly different from baseline, P = 0.003).
These effects were not only smaller than those produced by EDA (at 1mM), but were also slower in both onset and recovery (Fig. 8A) . Intracellular recordings showed that, like EDA, the dominant effect of adipic acid on CA1 neurones was one of depolarisation with increased membrane conductance but these responses were unaffected by bicuculline (20µM) or strychnine (20µM) (data not shown).
In view of the structural similarity between EDA monocarbamate and adipic acid and α-amino-adipic acid (αAA), and the fact that the latter compound was one of the earliest antagonists to be identified at glutamate receptors (Biscoe et al., 1977) , the possibility was considered that EDA carbamates and adipic acid might both act as weak NMDA receptor agonists, and might be antagonised by αAA. However, this was not the case, and when superfused at a concentration of 1mM, αAA had no significant activity against the responses to either EDA or adipic acid (Fig. 8A,B) .
Role of extracellular bicarbonate
In order to pursue the question of whether the activity of EDA was attributable to complex formation with bicarbonate, 25% of the normal bicarbonate content of the aCSF was replaced by HEPES. This substitution reduced significantly the depression of evoked potentials by 1mM EDA from 75 ± 5% (n = 6) to 40 ± 5% (n = 6) (P < 0.001), while there was no change in the depression produced by 1mM GABA (controls 40 ± 5%, with HEPES 40 ± 5%, n = 6, n.s.).
Channel modulation
4,4'-di-isothiocyano-stilbene-2,2'-disulphonic acid (DIDS), a blocker of chloride / bicarbonate exchange, is known to block the conductance changes induced by GABA and hence to reduce its depolarising and hyperpolarising actions (Bonnet and Bingmann, 1995) . When tested against responses to EDA, DIDS (20µM) reduced substantially the depolarisation and depression of evoked potentials: the effect of 1mM EDA was reduced from 70 ± 5% (n = 8) to 20 ± 5% (n = 8) (P < 0.001), consistent with a similar site and mechanism of action between EDA and GABA.
In vivo experiments
In order to determine whether EDA had any effect on evoked potentials under more physiological conditions, the somatosensory evoked potential (SEP) was examined in anaesthetised rats. When applied for 5 min EDA (25mM) produced an initial shortlasting increase in the amplitude of the negative (N) phase of the SEP (by 12 ± 7%, n = 5), invariably followed by a decrease (by 30 ± 12%, n = 5) (Fig. 9A,B) . A higher concentration produced a much lower initial increase in the SEP but subsequently decreased it by 74 ± 5% (n = 5) (Fig 9B) . EDA at 5 mM did not affect the size or shape of the SEPs (n = 5).
To examine the role of GABA-A receptors in these effects, bicuculline was also applied topically at a concentration of 10µM for 15 min before and during the application of EDA. This compound increased the overall amplitude of the SEP by 77 ± 34% (n = 7) (Fig. 9C) , with the greatest change occurring in the positive (P) phase of the potential. However, the application of EDA (in the continued presence of bicuculline) still caused an immediate and complete abolition of the evoked positive wave and a gradual decrease in the overall amplitude of the SEP by 22 ± 15% (n = 7). There was no significant difference in the degree of SEP depression caused by EDA on its own or in the presence of bicuculline (two-tailed t test; P = 0.40).
DISCUSSION
Although several agents are available with which to explore the pharmacology and physiological roles of GABA receptors, uptake and metabolism, there are few with which to probe neuronal or behavioural responses to the selective release of endogenous GABA. As noted in the Introduction EDA appeared to be an efficient GABA-mimetic, partly by inducing GABA release and partly by direct activation of GABA A receptors in the CNS Stone, 1980, 1982a; Blaxter and Cottrell,1985; Bokisch et al., 1984; Lloyd et al., 1982a,b) . The effects of EDA extended to the modulation of benzodiazepine binding (Morgan and Stone, 1982; Davies et al., 1982) .
The ability of EDA to release GABA is a result of the uptake of EDA itself by a nipecotic acid-sensitive transporter, possibly producing an exchange with GABA since the GABA release is calcium-independent (Lloyd et al., 1982a,b) . Here, nipecotic acid increased the size and duration of the EDA effects on fepsps, implying that the balance of nipecotic acid's activity is to prevent re-uptake of GABA rather than to reduce the initial uptake of EDA (since the EDA response would then be reduced).
The observation that EDA could produce a long-lasting depression in some slices could imply a modification of receptors -such as those for glutamate -involved in the generation of long-term depression (LTD), or could simply reflect the accumulation of EDA within the tissue. We consider the former explanation more likely given that the early time course of recovery was normal, the plateau of depression could be maintained for up to one hour, and that shorter (5min) applications of EDA appeared more likely to produce this LTD. Present experiments are being directed at further understanding of the mechanisms of the LTD.
Following the proposal that this GABA-mimetic activity might involve a complex formed between EDA and bicarbonate (Stone and Perkins, 1984) , strong supporting evidence for this hypothesis was obtained by demonstrating, physiologically and spectroscopically, the existence of EDA monocarbamate in solutions of EDA gassed with 5%CO 2 in oxygen (Curtis and Malik, 1984; Myers and Nelson, 1990) . Ejecting the active monocarbamate ion onto individual neurones resulted in a larger and more rapid depression of firing than was seen with EDA alone.
However, there has been little detailed systematic or quantitative work on the pharmacology of EDA and the present work was designed to pursue this. The profile of extracellular and intracellular recordings is consistent with previous work showing that somatic applications of GABA and EDA generate bicuculline-sensitive hyperpolarisations, while dendritic applications produce bicuculline-sensitive depolarisations (Blaxter and Cottrell, 1985) . The intracellular depolarisation presumably corresponds to the extracellularly recorded depression of fepsps.
Equally, the increase of fepsp size is most probably a result of the intracellularly recorded hyperpolarisation, both effects being resistant to bicuculline.
These results, together with the reduced responses to EDA in lowered extracellular bicarbonate therefore support the postulated activation of GABA receptors by EDA, probably via an EDA-bicarbonate complex. Perhaps more importantly, the present study has revealed an additional mechanism of action of EDA. Structurally, EDA monocarbamate is similar not only to GABA, but also to β-alanine (Fig. 10) , and EDA can release preloaded β-alanine as well as GABA from neurones (Davies et al., 1983) . Indeed, EDA is a more effective inhibitor of β-alanine uptake than of GABA uptake (Davies et al., 1982; Forster et al., 1981) , possible suggesting that EDA may be a better inhibitor of glial transport (β-alanine) than of neuronal uptake (GABA) (Davies et al., 1982) .
It is, therefore, intriguing to discover in this study that the effects of EDA are closely mimicked by applications of β-alanine, an amino acid recognised primarily for its ability to activate glycine receptors. Both EDA and β-alanine produced an initial increase of fepsp size preceding the reduction in their size, and both also produced intracellularly recorded depolarisations, often preceded by an underlying hyperpolarisation, with no fade being seen in the presence of the agonist. In contrast GABA itself was able to produce only a decrease of fepsp size and intracellular depolarisation, with both the extracellular and intracellular responses exhibiting marked fade after about several seconds of the GABA applications. However, despite these similarities, the effects of EDA and β-alanine remain largely distinct since the EDA-induced depression of fepsps and the intracellular depolarisation were blocked to a large extent, though not completely, by bicuculline, whereas these effects of β-alanine were blocked by strychnine.
The simplest interpretation of these data is that while EDA, almost certainly in the form of its monocarbamate, is able to activate GABA A receptors, and β-alanine is able to activate strychnine-sensitive, conventional, glycine A receptors, there is a third site which is resistant to bicuculline and strychnine at which both EDA and β-alanine, again in the form of their monocarbamates, produce hyperpolarisation when recorded intracellularly, and the increased fepsp size when recorded extracellularly. This response would correspond to the dendritic, bicuculline-resistant, hyperpolarisation observed by Blaxter and Cottrell (1985) when GABA was applied locally to the dendritic region. It has been proposed by others, based on a substantial amount of evidence on uptake, release and actions, that β-alanine could function as an independent neurotransmitter (DeFeudis and del Rio, 1977; Sandberg and Jacobson, 1981) .
The activity of EDA at sites which are resistant to blockade by bicuculline was noted both in hippocampal slices and at the somatosensory cortical surface in vivo.
In order to explain this bicuculline-resistant fraction of responses to EDA, two hypotheses were considered and tested in the slice preparation. Firstly, it is conceivable that EDA might form, in addition to the monocarbamate structure, a dicarbamate analogue which would resemble adipic acid in structure (Fig. 10 ). Such a complex might then activate classical excitatory amino acid receptors, or a distinct dicarboxylic acid receptor. The former possibility was tested using a high concentration of the general glutamate receptor antagonist kynurenic acid Stone and Darlington 2002) , but this compound failed to block the depression of antidromically-induced potentials or the intracellularly recorded depolarising responses to EDA, suggesting that activation of glutamate receptors cannot account for the results.
A role for an adipic acid receptor was also tested by applying adipic acid itself to the slices, where it did produce a depression of fepsps and an intracellular depolarisation. Those effects were not blocked by either bicuculline or strychnine, leaving open the possibility that EDA dicarbamate and adipic acid could act partly by a novel receptor site or transporter. Neither the EDA receptor nor the adipic acid site were blocked by α-aminoadipic acid, an antagonist at glutamate receptors (Biscoe et al., 1977; Stone, 1979) .
The blockade of EDA responses by DIDS strongly supports the involvement of common ionic mechanisms between GABA and EDA. In addition, it may be that the poor blockade of EDA effects by bicuculline reflects a direct action on GABA receptors distal to the site of action of GABA itself, explaining the common dependence on chloride but with recognisably distinct pharmacology. A direct action of some kind is certainly needed to account for the GABA-like effects in the absence of synaptic terminals (Morgan and Stone, 1982; Davies et al., 1982) and such an action, rather than activation of sites sensitive to agents such as β-alanine or adipic acid, could account for many of the present results.
The work in vivo provides an interesting comparison with the hippocampus in vitro.
The SEPs result from the depolarization of pyramidal cells by thalamo-cortical afferents. A subsequent positive wave due to the spread of depolarization to superficial cortical layers (I -III) is increased by the removal of tonic inhibition from GABAergic interneurons in these superficial layers (Addae et al. 2007; Jellema et al, 2004; Reyes et al. 1998) , confirming a role for endogenous GABA release. The results provide strong support to the findings in vitro. The profile of the trendplot of the SEPs shows an initial slight increase in the SEP size and a subsequent more prolonged decrease followed by recovery. The profile is similar to that seen in some of the in vitro recordings (e.g. Fig 3) .The in vivo profile is consistent with the report that depolarizing GABA responses are found in the superficial cortical layers where topical EDA is likely to exert its initial effect (DeFazio et al., 2005) . It is clear that EDA is able to exert a profound inhibitory action on SEPs similar to the inhibition noted in vitro. Also, and perhaps more importantly, the effects of EDA are at least partially resistant to bicuculline, since they are not prevented by concentrations of bicuculline that induce an increase of neuronal excitability sufficient to double the amplitude of an SEP and to induce multiple PS and spontaneous epileptiform activity in the neocortex. Indeed, this failure of bicuculline to block the EDA effects in vivo suggests that the direct effects of EDA on GABA receptors or channels noted above is relatively more important in vivo than it is in vitro.
Following the initial reports concerning EDA, it became clear that an interaction with bicarbonate or carbon dioxide was required for the excitatory and toxic action of β-N-methylamino-L-alanine (BMAA) at excitatory amino acid receptors (Myers and Nelson, 1990) . Also, high concentrations of neutral amino acids such as L-alanine and L-proline, can activate glutamate receptors (Pace et al., 1992) . C. chart summarising the decreased fepsp size produced by β-alanine (β-ala), the failure of bicuculline (bic) to modify that depression, and the blockade by strychnine (stry), and failure of bicuculline or strychnine to modify the initial increase in fepsp size produced by β-alanine. ** P < 0.01 (n = 4) compared with the control response to β-alanine alone.
Calibrations: 1mV, 10ms. A. illustrates a typical record of the depolarisation produced by EDA 300µM. The depolarisation is associated with an increase in membrane conductance, tested using 500ms pulses of hyperpolarising current (downward deflections). The upward deflections on the trace are spontaneous epsps which are suppressed by the membrane depolarisation. B. illustrates both the larger depolarisation and conductance change produced at 1mM EDA, and an underlying hyperpolarisation which occurs before and following the depolarisation (6 neurons). C. illustrates a neuron depolarised by EDA (500µM) in which, during the period indicated by the hatched bar, the membrane potential was manually clamped at the resting potential to confirm that the decrease of membrane resistance was still observed under these conditions.
Calibrations in A: 5mV and 1min; calibrations in B, C: 10mV and 1 min. Superimposed on that plot are responses after superfusion with α-aminoadipic acid (1mM, closed circles). There is no effect of α-aminoadipic acid on the response to adipic acid, although there is a small apparent reduction in the response to EDA.
B.
The overall analysis indicated that α-aminoadipic acid had no significant effect on the response to EDA or adipic acid. Data are shown as mean ± S.E.M. for n = 4. 
